<DOC>
	<DOCNO>NCT02470832</DOCNO>
	<brief_summary>The study conduct investigate effect itraconazole treatment pharmacokinetics RG1662 . It also evaluate exposure RG1662 vs. QTc response relationship safety tolerability RG1662 give combination itraconazole healthy subject .</brief_summary>
	<brief_title>A Study Investigate Effect CYP3A Inhibition Pharmacokinetics RG1662 Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<criteria>Male female volunteer Ages 18 60 year , inclusive A body mass index ( BMI ) 18 32 kg/m2 , inclusive Agreement comply study restriction History epilepsy , convulsion significant head injury electroencephalogram ( EEG ) abnormalities Electrocardiogram ( EGC ) vital sign abnormality Significant history drug allergy , determine Investigator , know hypersensitivity ingredient study treatment Use drug substance know substrate , inducer inhibitor CYP3A4 within 30 day first dose administration Pregnant lactate Any clinically relevant abnormality , concomitant disease ongoing medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>